Clinical trial
Megakaryocytes and Platelets, Harmful or Helpful in Breast Cancer Cell Metastasis
NCT06011824 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Megakaryocytes and Platelets, Harmful or Helpful in Breast Cancer Cell Metastasis
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 29, 2023
- Completion date
- April 29, 2025
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer